Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity

NCT02667015 is registered in ClinicalTrials.gov with Hartford Hospital as lead sponsor.

NCT NCT02667015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02667015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity
Lead sponsor
Hartford Hospital
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
May 31, 2015
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

other (or unknown) substance use disorders